Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec 19:14:1331169.
doi: 10.3389/fgene.2023.1331169. eCollection 2023.

Seventy-five years of service: an overview of the College of American Pathologists' proficiency testing program in histocompatibility and identity testing

Affiliations
Review

Seventy-five years of service: an overview of the College of American Pathologists' proficiency testing program in histocompatibility and identity testing

H Cliff Sullivan et al. Front Genet. .

Abstract

The Histocompatibility and Identity Testing Committee offers an overview of the College of American Pathologists' (CAP) Proficiency Testing (PT) program, commemorating its significant 75th anniversary in 2024. The CAP PT program has undergone significant growth and evolution over the years, ultimately achieving Centers for Medicare and Medicaid Services approval. In 1979, CAP's partnership with the American Association for Clinical Histocompatibility Testing marked a pivotal moment, leading to the creation of the first proficiency testing survey in 1980. This laid the foundation for various PT programs managed by the CAP Histocompatibility and Identity Testing Committee, including HLA antibody testing, HLA molecular typing, engraftment monitoring, parentage/relationship testing, HLA disease associations and drug risk, and HLA-B27 typing. Each program's distinctive considerations, grading methodologies, and future prospects are detailed here, highlighting the continual evolution of histocompatibility and identity testing PT to support emerging technologies and evolving laboratory practices in the field.

Keywords: College of American Pathologists (CAP); HLA antibody testing; HLA molecular typing; HLA-B27; disease association; histocompatibility and identity testing committee; monitoring engraftment; proficiency testing.

PubMed Disclaimer

Conflict of interest statement

Author GcM was employed by the Laboratory Corporation of America Holdings. Author JS was employed by the Versiti Wisconsin Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Electropherograms demonstrating stutter Electropherograms for the D21S11 short tandem repeat (STR) marker. The top panel is the electropherogram for the donor while the bottom panel is the electropherogram for the recipient pre-transplantation. The middle panel is the electropherogram for the recipient post-transplantation (allele, area = peak area, size = allele size). The post-transplant sample demonstrates that the recipient alleles (allele 28 and allele 30) are in the stutter of the donor alleles (allele 29 and allele 31). The presence of stutter peaks (represented by the smaller solid peaks) introduces complexity when attempting to interpret the percentage of donor and recipient contributions. This challenge arises due to the overlapping nature of recipient and donor markers. Typically, markers exhibiting stutter peaks are not considered informative for determining percent chimerism. Nevertheless, it is possible to utilize these markers if specific calculations are employed to accommodate for the average percent stutter associated with the particular marker in question.

Similar articles

References

    1. Abraha J., Rao P., Morris G. P. (2022). Modes of assay interference and the effectiveness of serum pretreatment approaches in detection of anti-HLA antibodies. J. Clin. Pathol. 2022, 208371. 10.1136/jcp-2022-208371 - DOI - PubMed
    1. Allen R. W., Eisenberg A., Harrison C., Walker R. H., Young C. T., Zeagler C. T., et al. (2003). Grading of qualitative and quantitative responses in the PI proficiency survey of the College of American Pathologists for mailings in 1997-2000. Int. Congr. Ser. 1239, 825–829. 10.1016/s0531-5131(02)00622-2 - DOI
    1. Anasetti C., Amos D., Beatty P. G., Appelbaum F. R., Bensinger W., Buckner C. D., et al. (1989). Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N. Engl. J. Med. 320 (4), 197–204. 10.1056/NEJM198901263200401 - DOI - PubMed
    1. Antin J. H., Childs R., Filipovich A. H., Giralt S., Mackinnon S., Spitzer T., et al. (2001). Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 tandem meetings of the international bone marrow transplant registry and the American society of blood and marrow transplantation. Biol. Blood Marrow Transpl. 7 (9), 473–485. 10.1053/bbmt.2001.v7.pm11669214 - DOI - PubMed
    1. Blouin A. G., Ye F., Williams J., Askar M. (2021). A practical guide to chimerism analysis: review of the literature and testing practices worldwide. Hum. Immunol. 82 (11), 838–849. 10.1016/j.humimm.2021.07.013 - DOI - PMC - PubMed